Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies
Titel:
Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies
Auteur:
Cahn, P. Madero, J. Sierra Arribas, J. Antinori, A. Ortiz, R. Clarke, A. Hung, C. Rockstroh, J. Girard, P. Sievers, J. Man, C. Urbaityte, R. Underwood, M. Tenorio, A. Pappa, K. Wynne, B. Gartland, M. Aboud, M. van Wyk, J. Smith, K. El-Bahy, Y.